News About: Pharm. Industry
Countermeasures on domestic market opening to foreign competition eyed
In the midst of the impending domestic market opening to foreign competition, much interest has been focused on the measures to alleviate non-tariff barriers and tariff cutting related to the WTO's DDA (Doha Developme...
Counterfeit Viagra is still rampant
Some counterfeit drugs on renowned brand items, such as Viagra and Xenical, are still rampant in the domestic market.
Market sources say that some harmful impurities may be contained in these drugs due to little in...
Domestic pharmaceutical industry have been in critical phase for survival
Pharmaceutical business sources say that a series of the government drug-related policies designed to unilaterally reduce the reimbursement prices, such as drug price re-evaluation system and ex post facto drug manage...
Domestic pharmaceutical firms to launch generic versions of blockbuster new drugs
A number of major pharmaceutical firms, including Chong Kun Dang, Hami Pharm, and Daewoong Pharm, are pushing to introduce most competitive generic versions of blockbuster new drugs amid the patent rights of multinati...
Janssen Korea launching non-narcotic pain killer, UltracetFollowing the United States market, Janssen's Ultracet, a non-narcotic compounded analgesic formulating with 325mg of Acetaminophen and 37.5mg of Tramadol Hcl has been launched ...
|
Bio and drug industry in need of government support for overseas development.
So called "bio industrial park" was planned to establish at the United States, which will be utilized as a stepping stone for the overseas market entry of the bio and pharmaceutical industry. However, the project has ...
Pharmaceutical business slump continues in fourth quarter
Influenced by the government drug-related policies to discourage the use of high-priced drugs and reduce the reimbursed prices continuously, a number of pharmaceutical firms are struggling to meet their year-end sales...
Generic drugs of Glivec to be directly imported next year
The group of leukemia patients and the Glivec publicity group said that as the generic products of Glivec produced by three-four pharmaceutical firms in India proven to be identical to Novartis's Glivec as a result of...
MR training can be made with reasonable expense through employment insurance premium
Any salesperson can easily complete the educational training program with the monthly training fee of 200,000 won a month within four months through the current subsidiary system for employees' vocational capacity dev...
New drug price re-evaluation system will affect sales of domestic pharmaceutical industry
The envisaged drug price re-evaluation system seems likely to significantly affect large-sized and foreign-invested pharmaceutical firms rather than medium- and small-sized firms, according to Hanyang Securities.
...
